Kestra Medical (KMTS) Technologies announced the appointment of Conor Hanley as an independent director to its board, effective June 4, 2025. Hanley is a chartered director and currently serves as CEO of FIRE1, a venture-backed connected medical device solutions company dedicated to improving outcomes for people with heart failure
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMTS:
- Optimistic Buy Rating for Kestra Medical Technologies Ltd. Driven by Strategic Expansion and Promising Financial Outlook
- Kestra Medical showcases real-world outcomes for ASSURE WCD
- Kestra Medical to exhibit at Heart Rhythm 2025
- Investors Turn Bullish on Kestra Medical Technologies Stock (KMTS) After Tepid Q3 Response
- Kestra Medical price target lowered to $23 from $24 at Goldman Sachs